Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... a leader in the field of human gene therapy, announced that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies ...
2009 NOV 2 ... of genetic disorders due to nonsense mutations. A pivotal phase 2b trial of ataluren in Duchenne muscular dystrophy is fully enrolled and results are anticipated in the first half of next year. A phase 3 ...
2009 NOV 16 ... dystrophin-deficient mdx mice,' is newly published data in Human Molecular Genetics. "Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin ...
2009 NOV 17 ... the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced the latest recipient of the End Duchenne Grant Award Program. ...
2009 NOV 9 ... will add to the growing body of data that we are compiling with our ongoing studies in Duchenne/Becker musculardystrophy and cystic fibrosis." Patients with hemophilia A ...
2009 NOV 9 ... According to recent research from Bern, Switzerland, "In Duchenne muscular dystrophy, deficiency of the cytoskeletal protein dystrophin leads to well-described defects in ...
2009 NOV 2 ... adrenal hyperplasia, which presents a more severe clinical course in males, and Duchenne muscular dystrophy." Christofidou and colleagues published their study in Reproductive ...
2009 NOV 9 ... in patients with muscular dystrophy. Of all the types of muscular dystrophy, Duchenne muscular dystrophy (DMD) and Becker dystrophy (BD) represent nearly all the anesthesia-related reports. ...
2009 NOV 16 ... apoptosis in C2C12 myoblasts. In skeletal muscle sections from the mdx mouse model of Duchenne muscular dystrophy, SLIMMER and Siva-1 co-localized in the nucleus of apoptotic myofibers," wrote D.L. ...
2009 NOV 17 ... complexes are the major laminin receptors in skeletal muscle. Loss of dystrophin causes Duchenne muscular dystrophy, a lethal muscle wasting disease," researchers in the United States report. ...
2009 NOV 11 ... "Mutations in the dystrophin gene (DMD) cause Duchenne and Becker muscular dystrophies and the majority of cases are due to DMD gene ... Keywords: United States, Houston, Life Sciences, Muscular Dystrophies, Muscular Dystrophy, Human Genetics, Baylor College of Medicine, College of Medicine. This ...
2009 NOV 16 ... degeneration,' have been published. According to a study from the United States, "Duchenne Muscular Dystrophy (DMD), caused by loss of dystrophin is characterized by progressive muscle cell ...
2009 NOV 1 ... the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), and his wife Stefanie Killian, announced that the 5th Annual Sam's Family ...
2009 NOV 3 ... of DMD, the gene that encodes dystrophin, underlie the fatal X-linked disease Duchenne muscular dystrophy. Oligonucleotides targeted to splicing elements (splice switching oligonucleotides) in ...
2009 NOV 9 ... of AAV-9.CMV.Delta R4-23/Delta C to mdx(3cv) mice, which we used as a model for Duchenne muscular dystrophy (DMD). Transgene expression was examined by histochemical as well as immunofluorescence ...
2009 NOV 23 ... strengthening has important implications for patients with muscle diseases including Duchenne muscular dystrophy - the most common form of muscular dystrophy - as well as for the planned first clinical ...
